Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension

M. J. West, L. M.H. Wing, J. Mulligan, J. Walkley, J. J. Grygiel, J. R. Graham, J. P. Chalmers

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

The efficacy of labetalol, an alpha and beta adrenoceptor blocking drug, has been compared with that of placebo, of propranolol alone, of hydrallazine alone, and of hydrallazine plus propranolol in combination in a randomized double‐blind, fixed‐dose crossover trial. Labetalol (300 mg twice a day) was equally effective with propranolol (80 mg twice a day), and more effective than hydrallazine (50 mg twice a day) alone. The effect of labetalol was comparable with that of hydrallazine plus propranolol when the patient was standing, but less potent with the patient in the supine position. Side effects were few.
Original languageEnglish
Pages (from-to)224-225
Number of pages2
JournalMedical Journal of Australia
Volume1
Issue number5
DOIs
Publication statusPublished - Mar 1980
Externally publishedYes

Fingerprint Dive into the research topics of 'Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension'. Together they form a unique fingerprint.

Cite this